Revised diagnostic criteria for neuromyelitis optica

By D. Wingerchuk, V. Lennon, S. Pittock, C. Lucchinetti, B. Weinshenker. Neurology, 2006

2,656 citations recorded by the source corpus.

Subfields: Neurology, Ophthalmology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/7dc439fa7b18adabb6088f6d54e0b87e43925a47

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

In Pathology and Forensic Medicine

Citations in the corpus

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. (2007, methodology): “%) to NMO, and NMO-IgG seropositive status is now incorporated in the revised diagnostic criteria of NMO (Lennon et al., 2004; Wingerchuk et al., 2006).”
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome (2016, methodology): “many MOG-IgG-positive patients with ON and/or myelitis met Wingerchuk’s revised 2006 diagnostic criteria for NMO [28], the new 2015 international diagnostic”
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011, background): “It is insufficient to make a diagnosis of NMO in the absence of the required specificity criteria of the revised Wingerchuk Criteria for ‘‘definite’’ NMO, which recommend presence of optic neuritis, acute myelitis, and at least 2 of 3 supportive paraclinical assessments (a contiguous spinal cord les”
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients (2012, background): “Besides AQP4-Ab, the length of the spinal cord lesions is thought to discriminate between NMO and MS with high specificity [36].”
Clinical presentation and prognosis in MOG-antibody disease: a UK study (2017, background): “NMOSD, ADEM and multiple sclerosis criteria in the Oxford total cohort Of the 53 adults (416 years), 47 fulfilled either the NMO 2006 (Wingerchuk et al., 2006) or NMOSD 2007 (Wingerchuk et al., 2007) criteria but only 17 fulfilled the NMOSD 2015 (Wingerchuk et al., 2015) criteria (because of the…”
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. (2007, background): “other organ-specific or non-organ-specific autoimmune disorders, and a variety of serum autoantibodies (O’Riordan et al., 1996; Wingerchuk et al., 2006).”
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing (2018, background): “Alternatively, should we restrict MOG-IgG testing to patients with AQP4-IgG-negative NMO according to Wingerchuk’s 2006 criteria [31]? This would again result in a substantial loss of patients at high risk of MOGEM, since those criteria require a history of both ON and myelitis and would thus be ina”
The Immunopathology of Multiple Sclerosis: An Overview (2007, background): “However, more recently it became clear that relapsing variants of Devic’s neuromyelitis optica are in fact more common, and lesions may extend beyond the spinal cord and the optic systems (72, 92, 93).”